Vanguard Fiduciary Trust
IMNM icon

Vanguard Fiduciary Trust’s Immunome IMNM Stock Holding History

Vanguard Fiduciary Trust’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Buy
756,297
+39,902
+6% +$854K ﹤0.01% 1566
2026
Q1 		$15.7M Buy
+716,395
New +$15.9M ﹤0.01% 1471

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Vanguard Fiduciary Trust's IMNM Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Immunome (IMNM) stake by 5.6% in Q2 2026, buying an estimated $854K and bringing the position to 756,297 shares worth $16M. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Vanguard Fiduciary Trust first reported a position in IMNM in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Vanguard Fiduciary Trust held 756,297 shares of Immunome worth $16M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 39,902 Immunome shares in Q2 2026, an estimated $854K.
  • Immunome made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1566 holding.
  • Vanguard Fiduciary Trust first reported a position in Immunome in Q1 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.